PDS Biotechnology
PDSB
PDSB
47 hedge funds and large institutions have $15.4M invested in PDS Biotechnology in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $19.2M → $15.4M (-$3.79M)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
47
Holding in Top 10
–
Calls
$2.05M
Puts
$241K
Top Buyers
| 1 | +$887K | |
| 2 | +$258K | |
| 3 | +$223K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$171K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$161K |
Top Sellers
| 1 | -$549K | |
| 2 | -$426K | |
| 3 | -$388K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$274K |
| 5 |
Renaissance Technologies
New York
|
-$204K |